影响泪腺的非特异性眼眶炎症的基因表达谱与异质性
该队列研究对48例患者(包括肉芽肿性多血管炎3例、非特异性眼眶炎症28例、结节病7例、甲状腺眼病4例及健康对照6例)的泪腺活检标本进行基因表达微阵列分析和组织病理学评估,发现基因表达谱可将标本分为4个亚群,显示泪腺炎症性疾病存在明显异质性,部分非特异性泪腺炎患者可能为局限型结节病,而另一些则与健康对照无法区分。
要点
- 基因表达谱将泪腺炎症活检标本分为4个亚群,显示疾病异质性。
- 多数结节病标本位于亚群1,该亚群肉芽肿评分最高。
- 32%(9/28)的非特异性眼眶炎症标本在亚群4中与健康对照无法区分。
核心结论
- 基因表达谱揭示泪腺炎症性疾病患者存在明显异质性。
- 表达谱比较提示部分非特异性泪腺炎患者可能为局限型结节病,而其他非特异性眼眶炎症患者与健康对照无法区分。
研究设计与样本
- 队列研究,纳入48例患者,包括肉芽肿性多血管炎3例、非特异性眼眶炎症28例、结节病7例、甲状腺眼病4例及健康对照6例。
- 标本来自7个国际中心(美国、沙特阿拉伯、加拿大、台湾)的眼整形外科医生,基因表达分析在俄勒冈健康与科学大学完成。
- 采用微阵列测量炎症与对照泪腺活检标本的基因表达水平,并对同一标本的染色切片进行组织病理学评估。
- 研究日期为2012年3月至2017年4月。
主要发现
- 48例患者平均(标准差)年龄41.6(19.0)岁,32例(67%)为女性。
- mclust算法将活检标本分为4个亚群,差异通过热图和多维标度图展示。
- 多数结节病活检标本位于亚群1,该亚群肉芽肿评分最高;亚群1中3例非特异性眼眶炎症标本无明显肉芽肿。
- 32%(9/28)的非特异性眼眶炎症活检标本在亚群4中与健康对照无法区分,其他非特异性眼眶炎症标本则倾向与肉芽肿性多血管炎或甲状腺眼病基因表达相似。
- 4个亚群可通过纤维化、肉芽肿和炎症病理评分部分区分,但无法通过淋巴结节评分区分。
关键数值与推荐
- 主要结局为基于已发表的约40个差异表达转录本列表(来自结节病患者血液、泪腺和眼眶脂肪组织)的基因表达对活检标本进行细分。
- 染色切片由2名独立且对临床诊断设盲的眼病理学家评估炎症(无、轻度、中度或重度)、肉芽肿、结节或纤维化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Although a variety of well-characterized diseases, such as sarcoidosis and granulomatosis with polyangiitis, affect the lacrimal gland, many patients with dacryoadenitis are diagnosed as having nonspecific orbital inflammation (NSOI) on the basis of histology and systemic disease evaluation. The ability to further classify the disease in these patients should facilitate selection of effective therapies. OBJECTIVE: To test the a priori hypothesis that gene expression profiles would complement clinical and histopathologic evaluations in identifying well-characterized diseases and in subdividing NSOI into clinically relevant groups. DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, gene expression levels in biopsy specimens of inflamed and control lacrimal glands were measured with microarrays. Stained sections of the same biopsy specimens were used for evaluation of histopathology. Tissue samples of patients were obtained from oculoplastic surgeons at 7 international centers representing 4 countries (United States, Saudi Arabia, Canada, and Taiwan). Gene expression analysis was done at Oregon Health & Science University. Participants were 48 patients, including 3 with granulomatosis with polyangiitis, 28 with NSOI, 7 with sarcoidosis, 4 with thyroid eye disease, and 6 healthy controls. The study dates were March 2012 to April 2017. MAIN OUTCOMES AND MEASURES: The primary outcome was subdivision of biopsy specimens based on gene expression of a published list of approximately 40 differentially expressed transcripts in blood, lacrimal gland, and orbital adipose tissue from patients with sarcoidosis. Stained sections were evaluated for inflammation (none, mild, moderate, or marked), granulomas, nodules, or fibrosis by 2 independent ocular pathologists masked to the clinical diagnosis. RESULTS: Among 48 patients (mean [SD] age, 41.6 [19.0] years; 32 [67%] female), the mclust algorithm segregated the biopsy specimens into 4 subsets, with the differences illustrated by a heat map and multidimensional scaling plots. Most of the sarcoidosis biopsy specimens were in subset 1, which had the highest granuloma score. Three NSOI biopsy specimens in subset 1 had no apparent granulomas. Thirty-two percent (9 of 28) of the NSOI biopsy specimens could not be distinguished from biopsy specimens of healthy controls in subset 4, while other examples of NSOI tended to group with gene expression resembling granulomatosis with polyangiitis or thyroid eye disease. The 4 subsets could also be partially differentiated by their fibrosis, granulomas, and inflammation pathology scores but not their lymphoid nodule scores. CONCLUSIONS AND RELEVANCE: Gene expression profiling discloses clear heterogeneity among patients with lacrimal inflammatory disease. Comparison of the expression profiles suggests that a subset of patients with nonspecific dacryoadenitis might have a limited form of sarcoidosis, while other patients with NSOI cannot be distinguished from healthy controls.
引用
- Rosenbaum JT, Choi D, Harrington CA, et al. Gene Expression Profiling and Heterogeneity of Nonspecific Orbital Inflammation Affecting the Lacrimal Gland. JAMA Ophthalmol. 2017. PMID: 28975236. doi:10.1001/jamaophthalmol.2017.3458
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。